Nunaps
PrivateLast Round
Series B
Jan 1, 2025
Total Funding Raised
$13.47M
Company Overview
Nunaps is a digital therapeutics company that develops software-based medical devices and platforms to treat and manage neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
digital therapeuticsDTxsoftware as a medical deviceSaMDvirtual reality therapyneuro-rehabilitationvisual field defectsmedical AIneuroplasticitystroke recoverydigital healthclinical-stage softwarehealthtechvisual perceptual learningneurological disorders
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nunaps Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nunaps Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 1, 2025 | ||||
| Series A | Jan 5, 2020 | ||||
| Seed | Dec 1, 2017 |
Nunaps Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hanwha Investment & Securities | Series B |
| K2 Investment Partners | Series A |
| Smilegate Investment | Series B |
| Prodigy Investment | VC Round |
| Company K Partners | Seed, Series A, Series B |
| Woori Venture Partners Co., Ltd. | Series B |
| Korea Development Bank | Series B |
Nunaps Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nunaps's valuation, stock price, and market status.
Firmographic Details
HeadquartersSeoul
Employee Range7
Year Founded2017
Last FundingJan 1, 2025